Jeng YM - Search Results

1

S100P as a marker for poor survival and advanced stage in gallbladder carcinoma.

Mathai AM, Alexander J, Huang HY, Li CF, Jeng YM, Fung KM, Harris WP, Swanson PE, Truong C, Yeh MM. Mathai AM, et al. Among authors: jeng ym. Ann Diagn Pathol. 2021 Jun;52:151736. doi: 10.1016/j.anndiagpath.2021.151736. Epub 2021 Mar 22. Ann Diagn Pathol. 2021. PMID: 33798925

2

Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities.

Jeng YM, Sung MT, Fang CL, Huang HY, Mao TL, Cheng W, Hsiao CH. Jeng YM, et al. Am J Surg Pathol. 2002 Mar;26(3):371-6. doi: 10.1097/00000478-200203000-00012. Am J Surg Pathol. 2002. PMID: 11859210

3

Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.

Liu SH, Lin CY, Peng SY, Jeng YM, Pan HW, Lai PL, Liu CL, Hsu HC. Liu SH, et al. Among authors: jeng ym. Am J Pathol. 2002 May;160(5):1831-7. doi: 10.1016/S0002-9440(10)61129-7. Am J Pathol. 2002. PMID: 12000734 Free PMC article.

4

Primary yolk sac tumor of the urachus.

Huang HY, Ko SF, Chuang JH, Jeng YM, Sung MT, Chen WJ. Huang HY, et al. Among authors: jeng ym. Arch Pathol Lab Med. 2002 Sep;126(9):1106-9. doi: 10.5858/2002-126-1106-PYSTOT. Arch Pathol Lab Med. 2002. PMID: 12204063 Free article.

5

Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma.

Yuan RH, Jeng YM, Pan HW, Hu FC, Lai PL, Lee PH, Hsu HC. Yuan RH, et al. Among authors: jeng ym. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5368-76. doi: 10.1158/1078-0432.CCR-07-1113. Clin Cancer Res. 2007. PMID: 17875765

6

ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.

Lin SY, Pan HW, Liu SH, Jeng YM, Hu FC, Peng SY, Lai PL, Hsu HC. Lin SY, et al. Among authors: jeng ym. Clin Cancer Res. 2008 Aug 1;14(15):4814-20. doi: 10.1158/1078-0432.CCR-07-5262. Clin Cancer Res. 2008. PMID: 18676753

7

RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.

Jeng YM, Chang CC, Hu FC, Chou HY, Kao HL, Wang TH, Hsu HC. Jeng YM, et al. Hepatology. 2008 Oct;48(4):1118-27. doi: 10.1002/hep.22459. Hepatology. 2008. PMID: 18802962

8

Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis.

Lee JC, Li CF, Fang FM, Wang JW, Jeng YM, Yu SC, Lin YT, Wu JM, Tsai JW, Li SH, Huang HY. Lee JC, et al. Among authors: jeng ym. Mod Pathol. 2010 Oct;23(10):1379-92. doi: 10.1038/modpathol.2010.128. Epub 2010 Jul 16. Mod Pathol. 2010. PMID: 20639860 Free article.

9

Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma.

Chen YL, Jeng YM, Hsu HC, Lai HS, Lee PH, Lai PL, Yuan RH. Chen YL, et al. Among authors: jeng ym. Int J Surg. 2013;11(1):85-91. doi: 10.1016/j.ijsu.2012.11.021. Epub 2012 Dec 13. Int J Surg. 2013. PMID: 23246869 Free article.

10

Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.

Lin CY, Chen ST, Jeng YM, Yeh CC, Chou HY, Deng YT, Chang CC, Kuo MY. Lin CY, et al. Among authors: jeng ym. J Oral Pathol Med. 2011 Oct;40(9):699-705. doi: 10.1111/j.1600-0714.2011.01019.x. Epub 2011 Feb 25. J Oral Pathol Med. 2011. PMID: 23647076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page